Advertisement

Index by author

November 01, 1987; Volume 15,Issue 6

  1. Magat, W J

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  2. Malejka-giganti, D

    1. Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
      D Malejka-Giganti, W J Magat, A M Adelmann and R W Decker
      Drug Metabolism and Disposition November 1987, 15 (6) 760-766;

  3. Malet-martino, M C

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  4. Malkinson, A M

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  5. Marriage, H J

    1. Metabolism of (+)-trans-delta 8-tetrahydrocannabinol in the mouse in vitro and in vivo.
      D J Harvey and H J Marriage
      Drug Metabolism and Disposition November 1987, 15 (6) 914-920;

  6. Martino, R

    1. 19F nuclear magnetic resonance analysis of the carbamate reaction of alpha-fluoro-beta-alanine (FBAL), the major catabolite of fluoropyrimidines. Application to FBAL carbamate determination in body fluids of patients treated with 5'-deoxy-5-fluorouridine.
      R Martino, M C Malet-Martino, C Vialaneix, A Lopez and M Bon
      Drug Metabolism and Disposition November 1987, 15 (6) 897-904;

  7. Mastovich, S L

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  8. Mclean, M A

    1. Pharmacokinetics and metabolism of the antitumor drug amonafide (NSC-308847) in humans.
      T B Felder, M A McLean, M L Vestal, K Lu, D Farquhar, S S Legha, R Shah and R A Newman
      Drug Metabolism and Disposition November 1987, 15 (6) 773-778;

  9. Mead, E W

    1. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
      J A Thompson, A M Malkinson, M D Wand, S L Mastovich, E W Mead, K M Schullek and W G Laudenschlager
      Drug Metabolism and Disposition November 1987, 15 (6) 833-840;

  10. Melder, D C

    1. Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation.
      G Powis, K S Santone, D C Melder, L Thomas, D J Moore and T J Wilke
      Drug Metabolism and Disposition November 1987, 15 (6) 826-832;
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement